Stock listing
Frankfurt:0RP Tiziana Life Sciences Ltd Aktie
German listing (Frankfurt) of Tiziana Life Sciences Ltd · home listing NASDAQ:TLSA
Follow Tiziana Life Sciences Ltd into a list and get an email when it puts out news.
Home listing price · NASDAQ:TLSA
$0.67 USD -0.13 (-16.3%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:TLSA
- Day range
- $0.643 – $0.858 USDNov 2, 2026
- Volume
- 2.85M sharesNov 2, 2026
- Market cap
- $85.26M USDAt the close on Nov 2, 2026 · price × 127.3M shares outstanding
- 52-week range
- $0.643 – $1.95 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $826,325 USDMedian day 564,200 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:TLSA · Home | $0.67 USD | -0.13 (-16.3%) | 2,847,678 | $0.84 | $0.858 | $0.643 | $0.80 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:TLSA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.67 | -0.13 | -16.3% | $0.84 | $0.858 | $0.643 | 2,847,678 | |
| $0.80 | -0.105 | -11.6% | $0.897 | $0.916 | $0.79 | 1,292,063 | |
| $0.905 | -0.045 | -4.8% | $0.95 | $0.95 | $0.90 | 187,612 | |
| $0.95 | +0.078 | +8.9% | $0.89 | $0.959 | $0.88 | 250,576 | |
| $0.872 | -0.01 | -1.2% | $0.88 | $0.943 | $0.872 | 189,420 | |
| $0.882 | -0.068 | -7.1% | $0.95 | $0.95 | $0.86 | 377,663 | |
| $0.95 | -0.05 | -5.0% | $0.97 | $0.98 | $0.93 | 252,000 | |
| $1.00 | -0.01 | -1.0% | $0.98 | $1.01 | $0.94 | 494,000 | |
| $1.01 | 0.00 | 0.0% | $1.03 | $1.03 | $0.97 | 421,500 | |
| $1.01 | 0.00 | 0.0% | $1.02 | $1.03 | $0.99 | 299,200 | |
| $1.01 | -0.04 | -3.8% | $1.06 | $1.07 | $0.99 | 332,500 | |
| $1.05 | 0.00 | 0.0% | $1.08 | $1.10 | $1.03 | 558,800 | |
| $1.05 | 0.00 | 0.0% | $1.05 | $1.07 | $1.02 | 264,400 | |
| $1.05 | -0.04 | -3.7% | $1.06 | $1.08 | $1.03 | 581,400 | |
| $1.09 | 0.00 | 0.0% | $1.09 | $1.12 | $1.05 | 492,600 | |
| $1.09 | -0.10 | -8.4% | $1.20 | $1.20 | $1.07 | 567,600 | |
| $1.19 | +0.06 | +5.3% | $1.14 | $1.25 | $1.13 | 2,423,400 | |
| $1.13 | +0.03 | +2.7% | $1.11 | $1.15 | $1.11 | 449,900 | |
| $1.10 | -0.01 | -0.9% | $1.11 | $1.14 | $1.07 | 384,600 | |
| $1.11 | +0.04 | +3.7% | $1.08 | $1.14 | $1.05 | 628,200 | |
| $1.07 | -0.05 | -4.5% | $1.12 | $1.14 | $1.07 | 274,400 | |
| $1.12 | -0.02 | -1.8% | $1.16 | $1.20 | $1.10 | 436,800 | |
| $1.14 | +0.03 | +2.7% | $1.11 | $1.19 | $1.09 | 697,700 | |
| $1.11 | +0.16 | +16.8% | $1.00 | $1.14 | $0.97 | 1,518,700 | |
| $0.95 | -0.03 | -3.1% | $0.98 | $1.03 | $0.94 | 511,300 | |
| $0.98 | -0.03 | -3.0% | $1.01 | $1.05 | $0.96 | 389,000 | |
| $1.01 | -0.03 | -2.9% | $1.03 | $1.08 | $1.00 | 382,700 | |
| $1.04 | -0.01 | -1.0% | $1.10 | $1.11 | $1.00 | 706,600 | |
| $1.05 | +0.16 | +18.0% | $0.89 | $1.06 | $0.89 | 1,573,700 | |
| $0.89 | -0.01 | -1.1% | $0.89 | $0.89 | $0.87 | 623,900 | |
| $0.90 | -0.01 | -1.1% | $0.94 | $0.95 | $0.90 | 534,300 | |
| $0.91 | -0.06 | -6.2% | $0.97 | $0.98 | $0.91 | 414,800 | |
| $0.97 | +0.20 | +26.0% | $0.85 | $1.01 | $0.85 | 1,743,200 | |
| $0.77 | -0.08 | -9.4% | $0.85 | $0.88 | $0.76 | 844,100 | |
| $0.85 | -0.04 | -4.5% | $0.89 | $0.89 | $0.81 | 659,200 | |
| $0.89 | -0.07 | -7.3% | $0.96 | $0.98 | $0.88 | 564,200 | |
| $0.96 | 0.00 | 0.0% | $0.98 | $1.00 | $0.93 | 272,900 | |
| $0.96 | -0.02 | -2.0% | $0.96 | $0.98 | $0.95 | 194,600 | |
| $0.98 | -0.01 | -1.0% | $0.99 | $1.01 | $0.95 | 245,500 | |
| $0.99 | -0.03 | -2.9% | $1.02 | $1.03 | $0.96 | 908,200 | |
| $1.02 | +0.05 | +5.2% | $0.97 | $1.06 | $0.95 | 573,900 | |
| $0.97 | +0.04 | +4.3% | $1.05 | $1.05 | $0.95 | 517,900 | |
| $0.93 | -0.03 | -3.1% | $0.96 | $1.00 | $0.91 | 487,800 | |
| $0.96 | -0.03 | -3.0% | $0.99 | $1.00 | $0.91 | 515,100 | |
| $0.99 | -0.02 | -2.0% | $1.02 | $1.05 | $0.97 | 429,700 | |
| $1.01 | -0.07 | -6.5% | $1.10 | $1.10 | $1.00 | 565,500 | |
| $1.08 | -0.01 | -0.9% | $1.09 | $1.14 | $1.05 | 272,300 | |
| $1.09 | -0.02 | -1.8% | $1.12 | $1.13 | $1.08 | 402,600 | |
| $1.11 | -0.04 | -3.5% | $1.18 | $1.18 | $1.10 | 441,000 | |
| $1.15 | +0.01 | +0.9% | $1.14 | $1.25 | $1.14 | 959,000 | |
| $1.14 | +0.02 | +1.8% | $1.12 | $1.17 | $1.09 | 832,300 | |
| $1.12 | +0.05 | +4.7% | $1.08 | $1.16 | $1.04 | 1,573,000 | |
| $1.07 | -0.05 | -4.5% | $1.12 | $1.17 | $1.02 | 2,092,100 | |
| $1.12 | -0.03 | -2.6% | $1.14 | $1.18 | $1.06 | 1,623,800 | |
| $1.15 | +0.01 | +0.9% | $1.15 | $1.17 | $1.05 | 1,915,800 | |
| $1.14 | +0.10 | +9.6% | $1.05 | $1.20 | $1.04 | 991,900 | |
| $1.04 | +0.05 | +5.1% | $0.99 | $1.09 | $0.99 | 1,519,200 | |
| $0.99 | -0.02 | -2.0% | $1.01 | $1.01 | $0.94 | 2,047,700 | |
| $1.01 | 0.00 | 0.0% | $1.01 | $1.01 | $0.97 | 414,700 | |
| $1.01 | +0.01 | +1.0% | $1.03 | $1.05 | $0.97 | 750,800 | |
| $1.00 | +0.03 | +3.1% | $0.99 | $1.03 | $0.96 | 982,100 | |
| $0.97 | -0.02 | -2.0% | $1.02 | $1.10 | $0.97 | 1,989,100 | |
| $0.99 | +0.02 | +2.1% | $0.97 | $1.08 | $0.95 | 985,000 | |
| $0.97 | 0.00 | 0.0% | $0.94 | $1.02 | $0.94 | 577,800 | |
| $0.97 | -0.06 | -5.8% | $1.00 | $1.11 | $0.89 | 3,012,500 |
- Ticker
- Frankfurt:0RP
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 21, 2026
Tiziana Management Team to Attend the 10th Joint ACTRIMS-ECTRIMS Meeting in Toronto
Latest deck · May 2026
Investor Presentation (May 2026)
Investor deck · 18 slides
Latest news
Tiziana Management Team to Attend the 10th Joint ACTRIMS-ECTRIMS Meeting in Toronto
Oct 21, 2026
Closed $1.01 (0.0%) on Oct 21, 2026
Tiziana Doses Last Patient in Phase 2 Trial of Intranasal Foralumab for Mild Alzheimer’s Disease
Oct 16, 2026
Closed $1.05 (0.0%) on Oct 16, 2026
Tiziana Life Sciences Files for Orphan Drug Designation with the FDA for Intranasal Foralumab for the Treatment of Multiple System Atrophy (MSA)
Sep 30, 2026
Closed $1.11 (+16.8%) on Sep 30, 2026
Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab
Sep 28, 2026
Closed $0.98 (-3.0%) on Sep 28, 2026
Tiziana Announces Last Patient Completes Last Visit in Phase 2a INFORM-MS Trial of Intranasal Foralumab
Sep 21, 2026
Closed $0.90 (-1.1%) on Sep 21, 2026
Tiziana Life Sciences Announces Signing of MOU with King Abdullah International Medical Research Center
Sep 17, 2026
Closed $0.97 (+26.0%) on Sep 17, 2026
Tiziana Life Sciences Announces Poster Presentation on Phase 2a BANYAN Clinical Trial of Intranasal Foralumab at ALS Nexus 2026
Aug 24, 2026
Closed $1.15 (+0.9%) on Aug 24, 2026
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
Aug 6, 2026
Closed $0.97 (-2.0%) on Aug 6, 2026
Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab
Jul 31, 2026
Closed $1.03 (+6.2%) on Jul 31, 2026
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman
Jun 15, 2026
Closed $1.11 (+0.9%) on Jun 15, 2026
Decks
Investor Presentation (May 2026)
Investor deck · 18 slides · May 2026
Investor Presentation (2026)
Investor deck · 19 slides · 2026
IPO Roadshow (December 2025)
IPO roadshow · 21 slides · Dec 12, 2025
Investor Presentation (December 2025)
Investor deck · 18 slides · December 2025
Tiziana Life Sciences Ltd on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 37 in the last 12 months · 195 in all · newest Oct 21, 2026 · oldest 2020
- Decks
- 13 decks · latest May 2026
Where Tiziana Life Sciences Ltd is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:TLSA · Home listing | NASDAQ | United States | USD |
| BOATS:TLSA | BOATS | United States | USD |
| Lang & Schwarz:A3C5SS | Lang & Schwarz | Germany | EUR |
| LS Exchange:A3C5SS | LS Exchange | Germany | EUR |
| gettex:0RP | gettex | Germany | EUR |
| Frankfurt:0RP · This page | Frankfurt | Germany | EUR |
| Dusseldorf:0RP | Dusseldorf | Germany | EUR |
| Munich:0RP | Munich | Germany | EUR |
| Stuttgart:0RP | Stuttgart | Germany | EUR |
| Tradegate:0RP | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Tiziana Life Sciences Ltd.